SCHEMBL8596239

SCHEMBL8596239

c1ccc(Nc2ncc[nH]2)nc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 5/20 0.58
ADRA2C P18825 5/20 0.58
ADRA1D P25100 2/20 0.58
ADRA1A P35348 2/20 0.58
ADRA1B P35368 2/20 0.58
MEN1 O00255 2/20 0.57
KMT2A Q03164 2/20 0.57
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
ALDH1A1 P00352 1/20 0.57
HPGD P15428 1/20 0.57
ALOX15 P16050 1/20 0.57
SMN1; SMN2 Q16637 1/20 0.57
MAPK10 P53779 1/20 0.55
GFER P55789 1/20 0.55
PIM1 P11309 1/20 0.47
ADRA2B P18089 2/20 0.47
PKM P14618 1/20 0.42
KDR P35968 3/20 0.42
CXCR4 P61073 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL221242 0.78 KMT2A (0.76) ADRA2AADRA2CMEN1KMT2ANPC1
SCHEMBL29391624 0.78 KMT2A (0.76) ADRA2AADRA2CMEN1KMT2ANPC1
SCHEMBL31690832 0.76 MEN1 (0.55) ADRA2AADRA2CMEN1KMT2ANPC1
SCHEMBL6574416 0.75 KMT2A (0.73) ADRA2AADRA2CMEN1KMT2ANPC1
Bromide SCHEMBL28368455 0.75 KMT2A (0.73) ADRA2AADRA2CMEN1KMT2ANPC1
SCHEMBL6175584 0.75 KMT2A (0.73) ADRA2AADRA2CMEN1KMT2ANPC1
SCHEMBL4243882 0.75 KMT2A (0.73) ADRA2AADRA2CMEN1KMT2ANPC1
SCHEMBL11133606 0.75 KMT2A (0.73) ADRA2AADRA2CMEN1KMT2ANPC1
SCHEMBL30947359 0.75 KMT2A (0.73) ADRA2AADRA2CMEN1KMT2ANPC1
SCHEMBL6175579 0.75 KMT2A (0.73) ADRA2AADRA2CMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220372136-A1 METHODS FOR TREATING ANEMIA OF CHRONIC DISEASE DISC MEDICINE, INC. (US) 2022-11-24 US disclosed
US-20220372135-A1 METHODS FOR TREATING MYELOFIBROSIS AND RELATED CONDITIONS DISC MEDICINE, INC. (US) 2022-11-24 US disclosed
EP-4041243-A1 METHODS FOR TREATING ANEMIA OF CHRONIC DISEASE Disc Medicine, Inc. (US) 2022-08-17 EP disclosed
EP-4041241-A1 METHODS FOR TREATING MYELOFIBROSIS AND RELATED CONDITIONS Disc Medicine, Inc. (US) 2022-08-17 EP disclosed
CN-114761013-A Methods of treating myelofibrosis and related disorders 迪斯克医药公司 2022-07-15 CN disclosed
WO-1998024776-A1 PREPARATION OF AN AMINOARYLAMINOARAZOLE THE DOW CHEMICAL COMPANY (US) 1998-06-11 WO disclosed
US-5739344-A Preparation of an aminoarylaminoarazole THE DOW CHEMICAL COMPANY (US) 1998-04-14 US disclosed